Qiming's Springhill backs AI medical imaging startup Infervision's $139m Series D round

Infervision, a Chinese startup that offers artificial intelligence (AI)-based medical imaging solutions, has closed a new investment that brings the firm’s total capital raise in its Series D round to nearly 900 million yuan ($139 million).

The investment is the second tranche of the Series D round, following the completion of its Series D1 round in November 2020. The startup did not disclose how much it raised respectively in the two tranches.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter